Schroder Investment Management Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-176,277
| Closed | -$6.58M | – | 1589 |
|
|
2021
Q2 | $6.58M | Sell |
176,277
-118,777
| -40% | -$4.43M | 0.01% | 772 |
|
|
2021
Q1 | $7.55M | Buy |
295,054
+55,661
| +23% | +$1.42M | 0.01% | 727 |
|
|
2020
Q4 | $5.27M | Buy |
239,393
+4,455
| +2% | +$98.1K | 0.01% | 790 |
|
|
2020
Q3 | $4.25M | Buy |
234,938
+15,424
| +7% | +$279K | 0.01% | 753 |
|
|
2020
Q2 | $5.58M | Sell |
219,514
-9,525
| -4% | -$242K | 0.01% | 662 |
|
|
2020
Q1 | $4.54M | Buy |
229,039
+119,349
| +109% | +$2.36M | 0.01% | 684 |
|
|
2019
Q4 | $2.42M | Buy |
109,690
+1,956
| +2% | +$43.1K | ﹤0.01% | 858 |
|
|
2019
Q3 | $1.64M | Buy |
+107,734
| New | +$1.64M | ﹤0.01% | 918 |
|